Wen-Wan Chao

Wen-Wan Chao is a notable inventor based in Changhua, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 2 patents, Chao's work focuses on the use of deoxyelephantopin (DET) and its analogues in reducing side effects of anti-cancer agents and treating melanoma.

Latest Patents

Chao's latest patents include methods for preventing and/or reducing side effects of an anti-cancer agent. These methods involve administering a composition that contains a therapeutically effective amount of isolated deoxyelephantopin and/or an analogue, along with a pharmaceutically acceptable carrier. Another significant patent addresses the treatment of melanoma, detailing methods for administering a composition that includes a therapeutically effective amount of deoxyelephantopin or its analogue, also accompanied by a suitable carrier. These patents highlight his commitment to improving cancer treatment outcomes.

Career Highlights

Wen-Wan Chao is affiliated with Academia Sinica, where he conducts his research. His work has garnered attention for its potential to enhance the efficacy of cancer treatments while minimizing adverse effects. Chao's innovative approaches are paving the way for new therapeutic strategies in oncology.

Collaborations

Chao collaborates with esteemed colleagues, including Lie-Fen Shyur and Ya-Wen Cheng. Their combined expertise contributes to the advancement of research in cancer therapies.

Conclusion

Wen-Wan Chao's contributions to cancer treatment through his innovative patents demonstrate his dedication to improving patient care. His work with deoxyelephantopin offers promising avenues for reducing side effects and treating melanoma effectively.